EN 3285
Alternative Names: Acetylcysteine oral rinse - Endo; N-acetylcysteine oral rinse - Endo; NAC Oral Rinse; RK 0202Latest Information Update: 24 Oct 2021
At a glance
- Originator Elan Corporation; RxKinetix
- Developer Endo Pharmaceuticals
- Class Anti-inflammatories; Antibronchitics; Antidotes; Expectorants; Reducing agents; Small molecules; Sulfur amino acids
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stomatitis